ESTRO 36 Programme book and exhibition guide

emission imaging are attracting a lot of attention, but the developments of computerised tomography (CT) is also significant. The session will provide an overview of some of the latest advancements in CT and their potential to improve current practice in radiotherapy.

SATURDAY 6 MAY 2017

Chair: T. Nyholm (Sweden) Co-chair: M. Aznar (Denmark)

08:45 > Current status and potential of dual energy and spectral CT Speaker: J. Andersson (Sweden) 09:10 > CT image quality: Using a model observer for clinically relevant optimisation Speaker: N. Ryckx (Switzerland) 09:35 > The potential of new CT technologies for radiotherapy with photons and protons Speaker: W. Van Elmpt (The Netherlands) SYMPOSIUM High tech or low tech for metastatic disease, how does one decide and what is the cost-benefit? 08:45 - 10:00 | STRAUS 1 This session will explore the potential for curative treatment in metastatic disease, available treatment options, ‘pros’ and ‘cons’ of using high technology in metastatic disease, the limitations and the presence or absence of clear patient selection criteria. The findings of a single institutions study on clinician preference for low and high technology will be presented. With respect to palliation the patient perception of a single fraction option for painful bone metastases and the application of LEAN Six Sigma in optimising work-flow. The final presentation will outline trial findings on technical equipment and medical staff resource requirements for stereotactic radiotherapy and radiosurgery (QUIRO-DEGRO trial)

SP-0022

SP-0023

SP-0024

Chair: M. Coffey (Ireland) Co-chair: A. Wegmayr (Austria)

08:45 > High tech approaches for curative treatment, when is enough enough? Speaker: J. Kazmierska (Poland) 09:10 > Optimising the workflow of palliative treatment using Lean Six Sigma methodology Speaker: M. Kamphuis (The Netherlands)

SP-0025

SP-0026

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

76